Bernzott Capital Advisors’s Zimmer Biomet ZBH Stock Holding History

Bernzott Capital Advisors’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-34,429	Closed	-$3.9M	–	38
2025 Q1	$3.9M	Buy	34,429 +849	+3%	+$90.8K	1.92%	32
2024 Q4	$3.55M	Sell	33,580 -6,432	-16%	-$690K	1.75%	34
2024 Q3	$4.32M	Sell	40,012 -864	-2%	-$94.3K	1.86%	32
2024 Q2	$4.44M	Sell	40,876 -4,775	-10%	-$563K	2.04%	32
2024 Q1	$6.03M	Buy	45,651 +1,947	+4%	+$243K	2.39%	30
2023 Q4	$5.32M	Sell	43,704 -854	-2%	-$95.3K	2.08%	28
2023 Q3	$5M	Sell	44,558 -6,517	-13%	-$828K	1.72%	33
2023 Q2	$7.44M	Buy	51,075 +4,182	+9%	+$568K	1.61%	33
2023 Q1	$6.06M	Sell	46,893 -3,985	-8%	-$500K	1.25%	41
2022 Q4	$6.49M	Sell	50,878 -29,225	-36%	-$3.39M	0.84%	43
2022 Q3	$8.38M	Buy	80,103 +1,184	+2%	+$130K	1.16%	38
2022 Q2	$8.29M	Buy	78,919 +18,288	+30%	+$2.17M	0.92%	40
2022 Q1	$7.75M	Sell	60,631 -2,207	-4%	-$266K	0.71%	41
2021 Q4	$7.75M	Sell	62,838 -2,644	-4%	-$346K	0.67%	42
2021 Q3	$9.3M	Buy	65,482 +36,980	+130%	+$5.44M	0.84%	40
2021 Q2	$4.45M	Buy	28,502 +806	+3%	+$131K	0.38%	43
2021 Q1	$4.3M	Sell	27,696 -2,491	-8%	-$386K	0.38%	39
2020 Q4	$4.52M	Sell	30,187 -2,088	-6%	-$295K	0.41%	38
2020 Q3	$4.27M	Buy	32,275 +2,549	+9%	+$333K	0.4%	35
2020 Q2	$3.44M	Sell	29,726 -1,143	-4%	-$132K	0.43%	36
2020 Q1	$3.03M	Sell	30,869 -3,250	-10%	-$426K	0.47%	37
2019 Q4	$4.96M	Buy	34,119 +1,926	+6%	+$266K	0.52%	38
2019 Q3	$4.29M	Sell	32,193 -412	-1%	-$53.2K	0.51%	38
2019 Q2	$3.73M	Sell	32,605 -478	-1%	-$56K	0.45%	38
2019 Q1	$4.1M	Sell	33,083 -113	-0.3%	-$12.8K	0.5%	39
2018 Q4	$3.34M	Hold	33,196	–	–	0.47%	40
2018 Q3	$4.24M	Hold	33,196	–	–	0.49%	40
2018 Q2	$3.59M	Sell	33,196 -103	-0.3%	-$11.2K	0.45%	38
2018 Q1	$3.52M	Sell	33,299 -1,190	-3%	-$138K	0.46%	35
2017 Q4	$4.04M	Buy	34,489 +7,133	+26%	+$807K	0.53%	35
2017 Q3	$3.11M	Sell	27,356 -226	-0.8%	-$26.1K	0.44%	37
2017 Q2	$3.44M	Sell	27,582 -206	-0.7%	-$24.4K	0.57%	35
2017 Q1	$3.29M	Sell	27,788 -522	-2%	-$59.2K	0.57%	36
2016 Q4	$2.84M	Buy	28,310 +505	+2%	+$54.1K	0.48%	37
2016 Q3	$3.51M	Sell	27,805 -1,153	-4%	-$142K	0.65%	36
2016 Q2	$3.38M	Sell	28,958 -1,339	-4%	-$152K	0.66%	38
2016 Q1	$3.14M	Sell	30,297 -515	-2%	-$49.8K	0.6%	37
2015 Q4	$3.07M	Sell	30,812 -103	-0.3%	-$10.1K	0.6%	37
2015 Q3	$2.82M	Sell	30,915 -258	-0.8%	-$25.9K	0.65%	37
2015 Q2	$3.31M	Sell	31,173 -257	-0.8%	-$28.4K	0.71%	36
2015 Q1	$3.59M	Sell	31,430 -4,249	-12%	-$485K	0.8%	34
2014 Q4	$3.93M	Sell	35,679 -8,910	-20%	-$939K	0.85%	37
2014 Q3	$4.35M	Sell	44,589 -4,923	-10%	-$484K	1.02%	35
2014 Q2	$4.99M	Sell	49,512 -1,257	-2%	-$123K	1.14%	33
2014 Q1	$4.66M	Sell	50,769 -1,256	-2%	-$116K	1.11%	35
2013 Q4	$4.71M	Sell	52,025 -1,648	-3%	-$143K	1.07%	34
2013 Q3	$4.28M	Sell	53,673 -114	-0.2%	-$8.97K	1.08%	37
2013 Q2	$3.91M	Buy	+53,787	New	+$4.02M	1.07%	36

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Bernzott Capital Advisors's ZBH Position: Q2 2025 in Review

Bernzott Capital Advisors sold out of Zimmer Biomet (ZBH) in Q2 2025, closing a stake of 34,429 shares — an estimated $3.9M sold.

Bernzott Capital Advisors first reported a position in ZBH in Q2 2013 and held it in 48 quarters. The position peaked at $9.3M in Q3 2021. 934 funds tracked by Wall St. Rank hold ZBH as of Q2 2025.

Bernzott Capital Advisors reported no remaining Zimmer Biomet position as of Q2 2025 after selling out during the quarter.
Bernzott Capital Advisors sold 34,429 Zimmer Biomet shares in Q2 2025, an estimated $3.9M.
Bernzott Capital Advisors first reported a position in Zimmer Biomet in Q2 2013 and held it in 48 quarters.
Bernzott Capital Advisors's Zimmer Biomet position peaked at $9.3M in Q3 2021.
934 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2025.

Based on Bernzott Capital Advisors's 13F filing for Q2 2025, filed 30 Jul 2025.